NIBEC Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2004-01-27
- Employees
- 101
- Market Cap
- -
- Website
- http://www.nibec.co.kr
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction
Not Applicable
Recruiting
- Conditions
- Alveolar Ridge Augmentation
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- NIBEC Co., Ltd.
- Target Recruit Count
- 114
- Registration Number
- NCT06783660
- Locations
- 🇰🇷
Seoul National University Dental Hospital, Korea, Seoul, Korea, Republic of
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
Phase 1
Recruiting
- Conditions
- Healthy Adult VolunteersActive Ulcerative ColitisActive Ulcerative Colitis (UC)
- Interventions
- Drug: NP-201 acetate injection (Part A)Drug: Placebo
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- NIBEC Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06681389
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
News
No news found